European Cancer Summit 2022

Delivering Effective & Equitable Care Together

We are looking forward to this year’s European Cancer Summit focused on the most important topics in cancer for a wide-ranging discussion focused on delivery and collaboration. In these turbulent times, with huge pressures on cancer services across Europe, we are bringing together leading oncology experts, patient advocates, politicians and policy makers. We have an exciting programme and speaker line-up, so we can discuss the main issues impacting cancer policy, for the benefit of cancer patients, healthcare professionals and all people across Europe.   

This year's Summit will be hosted in Brussels and we look forward to the majority of delegates joining in person, but will also be available to join virtually. We invite everyone interested to save the date – 16 & 17 November 2022.  

16 November 2022 8:45 - 18:15 CET 17 November 2022 9:00 - 18:30 CET

Brussels and Virtual

Apply for Registration

Every year, at the European Cancer Summit, the European Cancer Organisation brings together leading oncology experts, experienced patient advocates, key opinion leaders, policy makers and politicians to discuss key issues in reducing the burden of cancer, saving, and improving the lives of patients and the public.  

This year’s European Cancer Summit on 16-17 November will focus on delivery and collaboration, including through our  ten  Focused Topic Networks.  

We are planning this year’s Summit as a hybrid event with the majority of speakers and delegates meeting face-to-face in Brussels and others able to join virtually, bringing together the European cancer community including our Member Societies and Patient Advocacy groups.  

The European Cancer Summit is a key event in the cancer policy calendar. Our goal is to showcase the multi-stakeholder, collaborative efforts being made, to ensure tangible results. We believe this exchange will help to improve outcomes for cancer patients and raise awareness of the many significant challenges of cancer.  

View the highlights video from the hybrid  2021 European Cancer Summit and read the report

 

High-Level Speakers 

We already have leading speakers and panellists confirmed and you can see who will be joining us "on stage" here

Sessions with Relevance & Impact 

The European Cancer Summit 2022 Programme co-chairs Ajay Aggarwal and Gilliosa Spurrier-Bernard are guiding the development of an impactful programme with leading speakers and will have more news to share in the coming weeks.

View the programme here.  

 

visit brussels Brussels Capital

 

 

 

With the support of visit.brussels and the Brussels-Capital Region

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge Regional Director, World Health Organization Europe (WHO Europe)
  • Jakub Dvořáček Deputy Health Minister for the Czech Presidency of the Council of the European Union
  • Sara Cerdas MEP Board Member, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Deirdre Clune MEP Member, Special Committee on the Covid-19 Pandemic (COVI)

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge Regional Director, World Health Organization Europe (WHO Europe)
  • Jakub Dvořáček Deputy Health Minister for the Czech Presidency of the Council of the European Union
  • Sara Cerdas MEP Board Member, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Deirdre Clune MEP Member, Special Committee on the Covid-19 Pandemic (COVI)

European Cancer Summit 2022 Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge Regional Director, World Health Organization Europe (WHO Europe) Read Bio
  • Jakub Dvořáček Deputy Health Minister for the Czech Presidency of the Council of the European Union Read Bio
  • Sara Cerdas MEP Board Member, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI) Read Bio
  • Deirdre Clune MEP Member, Special Committee on the Covid-19 Pandemic (COVI) Read Bio
  • Nicolás González Casares MEP Member, Committee on the Environment, Public Health and Food Safety (ENVI) Read Bio
  • Kateřina Konečná MEP Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Alin Mituta MEP Member, Special Committee on the Covid-19 Pandemic (COVI) Read Bio
  • Dolors Montserrat MEP Rapporteur, Special Committee on the COVID-19 pandemic (COVI) and Former Spanish Health Minister
  • Alessandra Moretti MEP Member, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI)
  • Tomislav Sokol MEP Secretary General, EU40 and Member, Special Committee on the Covid-19 Pandemic (COVI) Read Bio
  • Nicolae Ștefănută MEP Board Member, EU40, and Member, Committee on the Environment, Public Health and Food Safety (ENVI)
  • Véronique Trillet-Lenoir MEP Member, Special Committee on the Covid-19 pandemic (COVI) Read Bio
  • Sandra Gallina Director-General, DG SANTE
  • Bente Mikkelsen Director, Non-communicable Diseases, World Health Organization (WHO) Read Bio
  • Andre Ilbawi Cancer Control Officer, World Health Organization (WHO)
  • Natasha Azzopardi-Muscat Director of the Division of Country Health Policies and Systems, WHO Europe Read Bio
  • Eric Winer President, American Society of Clinical Oncology (ASCO)
  • Jean-Yves Blay President, French Federation of Cancer Centres, Unicancer Read Bio
  • Caroline Berchet Health Economist, OECD Read Bio
  • Richard Sullivan Director, Institute of Cancer Policy; Editor-in-Chief, Journal of Cancer Policy; Emergency Committee Member, World Health Organization (WHO)
  • Roman Shyyan Surgical Oncologist, Lviv State Regional oncology treatment and diagnostic Center, Ukraine
  • David Collingridge Editor-in-chief, The Lancet Oncology Read Bio
  • Bettina Ryll Founder, Melanoma Patient Network Europe
  • Gilberto Lopes Editor-in-chief, JCO Global Oncology, American Society of Clinical Oncology (ASCO) Read Bio
  • Anna Uzlova CEO, Charity Foundation "Inspiration Family" and Cancer Survivor
  • Dorothy Keefe Chief Executive Officer, Cancer Australia Read Bio
  • Andreas Charalambous President, European Cancer Organisation
  • Ajay Aggarwal Co-Chair, European Cancer Summit 2022, and Board Member, European Cancer Organisation
  • Gilly Spurrier-Bernard Co-Chair, European Cancer Summit 2022, and Vice-Chair, European Cancer Organisation's Patient Advisory Committee
  • Patrick Howard Penile Cancer Survivor Read Bio
  • Stefan Constantinescu President, Federation of European Academies of Medicine
  • Aasim Yusuf Chief Medical Officer, Gastroenterologist, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan
  • Clare Bennett Reader, School of Healthcare Sciences and co-Director, Wales Centre for Evidence Based Care
  • Daisy Le Assistant Research Professor of Health Disparities and Oncology, George Washington University School of Nursing
  • Laurence Court Director of The Radiation Planning Assistant Project, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center Read Bio
  • Gauthier Bouche Director of Clinical Research, Anticancer Fund
  • Michail Ignatiadis Chair of the Breast Cancer Group, European Organization for Research and Treatment of Cancer (EORTC) Read Bio
  • Cinzia Brunelli Researcher, Istituto Nazionale Dei Tumori, Milan, Italy
  • Rebecca Fitzgerald Co-Chair of SAPEA Project and Professor of Cancer Prevention, University of Cambridge Read Bio
  • Jan Van Der Meulen Professor of Clinical Epidemiology, London School of Hygiene and Tropical Medicine Read Bio
  • Katie Spencer Academic Clinical Oncologist, University of Leeds, UK Read Bio
  • Yvonne Wengström Professor, Karolinska Institute
  • Ebba Hallersjö Hult Co-founder and Head of Vision Zero Cancer Read Bio
  • Alexandru Eniu Deputy Scientific Director, European School of Oncology (ESO) Read Bio
  • Kim Benstead Co-Chair, INTERACT-EUROPE project and Chair of ACOE Read Bio
  • Niall O'Higgins Co-Chair, INTERACT-EUROPE Project and a former President of ECO Read Bio
  • Matti Aapro Chair, INTERACT-EUROPE Advisory Board, and Past President, European Cancer Organisation Read Bio
  • Natacha Bolaños Head, Membership and Alliances, Lymphoma Coalition and Member, Patient Advisory Committee, European Cancer Organisation
  • Anita Kienesberger Chair, Childhood Cancer International Europe Committee and Member, Patient Advisory Committee, European Cancer Organisation Read Bio
  • Jan Geissler CEO and Founder, Patvocates and Member, Patient Advisory Committee, European Cancer Organisation
  • Rachel Giles Chair, International Kidney Coalition and Member, Patient Advisory Committee, European Cancer Organisation Read Bio
  • Anne-Marie Baird President, Lung Cancer Europe and Member, Patient Advisory Committee, European Cancer Organisation Read Bio
  • Teodora Kolarova Executive Director, International Neuroendocrine Cancer Alliance and Member, Patient Advisory Committee, European Cancer Organisation Read Bio
  • Estelle Lecointe Co-Chair, Sarcoma Patients Euro Net Association and Member, Patient Advisory Committee, European Cancer Organisation
  • Denis Costello Executive director, CML Advocates Network
  • Nicolò Battisti Co-Chair, Inequalities Network, European Cancer Organisation
  • Carlo Catalano Co-Chair, Digital Health Network, European Cancer Organisation
  • Sarah Collen Co-Chair, Inequalities Network, European Cancer Organisation
  • Mirjam Crul Board Member and Co-Chair, Workforce Network and Special Network on the Impact of Covid-19 on Cancer, European Cancer Organisation Read Bio
  • Csaba Dégi Board Member and Co-Chair, Survivorship and Quality of Life Network, European Cancer Organisation Read Bio
  • Daniel Kelly Co-Chair, HPV Action Network, European Cancer Organisation
  • Denis Lacombe Co-Chair, Health Systems and Treatment Optimisation Network, European Cancer Organisation
  • Mark Lawler Board Member and Co-Chair, Special Network on the Impact of Covid-19 on Cancer
  • Yolande Lievens Co-Chair, Health Systems and Treatment Optimisation, European Cancer Organisation
  • Rui Medeiros Co-Chair, HPV Action Network, European Cancer Organisation
  • Simon Oberst Board Member and Co-Chair, Quality Cancer Care Network, European Cancer Organisation
  • Wendy Oldenmenger Board Member and Co-Chair, Workforce Network, European Cancer Organisation
  • Fedro Peccatori Board Member and Co-Chair, Quality Cancer Care Network, European Cancer Organisation
  • Wim Oyen Treasurer and Co-Chair, Digital Health Network, European Cancer Organisation
  • Beate Rau Board Member and Co-Chair, Workforce Network, European Cancer Organisation
  • Isabel Teresa Rubio Board Member and Co-Chair, Prevention, Early Detection and Screening Network, European Cancer Organisation
  • Nevenka Krčevski Škvarč Co-Chair, Survivorship and Quality of Life Network, European Cancer Organisation
  • Jan van Meerbeeck Co-Chair, Prevention, Early Detection and Screening Network, European Cancer Organisation
  • Alexander Zehnder Global Head of Oncology, Sanofi Read Bio
  • Amadou Diarra Senior Vice President, Global Policy and Government Affairs, Bristol Myers Squibb (BMS)
  • Markus Kosch Head of the European Oncology Business Division, Daiichi Sankyo Read Bio
  • Sebastian Arias Global Access Policy Leader, Roche Read Bio
  • Gavin Lewis Vice-President, Global Head of Market Access, Amgen
  • Jamie Partridge Senior Director of Global Market Access, Bayer Pharmaceuticals Read Bio
  • Andy Powrie-Smith Executive Director of Communications & Partnerships, European Federation of Pharmaceutical Industries and Associations (EFPIA) Read Bio
  • Faisal Mehmud Vice President, International Developed Markets Medical Head, Pfizer Oncology Read Bio

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge Regional Director, World Health Organization Europe (WHO Europe)
  • Jakub Dvořáček Deputy Health Minister for the Czech Presidency of the Council of the European Union
  • Sara Cerdas MEP Board Member, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Deirdre Clune MEP Member, Special Committee on the Covid-19 Pandemic (COVI)

European Cancer Summit 2022 Registration

We invite everyone interested in attending the European Cancer Summit 2022 to register below. 

For delegates planning to come to Brussels, we have secured preferential accommodation rates/conditions in the Summit hotel for delegates joining us at the Summit venue ‘Radisson Collection Hotel, Grand Place Brussels’.  For the best available rates and booking conditions, please click here. Enter the dates of your stay, and within the special rate drop-down menu, enter the SUMMIT22 promotional code received upon registration. Please note that the European Cancer Organisation is not responsible for any travel, hotel or cancellation costs . 

Please note that the same registration rate applies for both in-person attendance in Brussels and virtual participation. We will be contacting registered delegates in October to check whether you will be coming to the Summit in person, or joining virtually. Please note that the special rate was only available up until 15 September.

Cancelled registrations are not refundable, but can be eligible for a change of name for €175.  Please contact us if you have any questions. 

  • Select your profile

    Please note that this information will be verified
    Standard Rate
    Special Rate Ended 15 September
  • 175
  • 75
  • 250
  • 400
  • 250

Complete the information below

I agree that my data will be used for registration purposes and to create a participant list that will be circulated at the event
I also want to subscribe to the European Cancer Organisation's newsletter
Upload the proof of membership

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge Regional Director, World Health Organization Europe (WHO Europe)
  • Jakub Dvořáček Deputy Health Minister for the Czech Presidency of the Council of the European Union
  • Sara Cerdas MEP Board Member, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Deirdre Clune MEP Member, Special Committee on the Covid-19 Pandemic (COVI)

European Cancer Summit 2022 Programme

 

Wednesday 16 November 2022

8:45-9:00 Opening Session

With Andreas Charalambous, European Cancer Organisation's President, Ajay Aggarwal and Gilly Spurrier-Bernard, European Cancer Summit 2022 Co-Chairs

9:00-10:15 Action on Cancer Inequalities: Our Shared Roadmap

This has been a year of turning plans into action. Notable amongst these is the publication of the first iteration of a new EU Cancer Inequalities Registry, and the start of several Beating Cancer Plan initiatives, including:  an EU Network of Comprehensive Cancer Centres; a European-wide campaign against HPV cancers; and an inter-speciality cancer training programme.

In addition, this opening session will officially launch the landmark report ‘European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission’. Its 12 evidence-based recommendations provide a roadmap to achieving a 70% survival rate, on average, for all cancer patients in Europe by 2035.

The European Cancer Organisation will also share a new tool developed by its Inequalities Network, the European Cancer Pulse. It provides an extensive complement to the EU Cancer Inequalities Registry and will highlight a range of additional cancer inequalities across the continent.  

With Inequalities Network Co-Chairs Nicolò Matteo Luca Battisti and Sarah Collen, including speakers:

  • Caroline Berchet, Health Economist OECD, Health Division
  • Richard Sullivan, Director, Institute of Cancer Policy; Editor-in-Chief, Journal of Cancer Policy; Emergency Committee Member, World Health Organization (WHO)
  • David Collingridge, Editor-in-Chief of The Lancet Oncology
  • Mark Lawler, Board Member, European Cancer Organisation
  • Teodora Kolarova, Executive Director, International Neuroendocrine Cancer Alliance (INCA), and Member, Patient Advisory Committee, European Cancer Organisation
  • Amadou Diarra, Senior Vice President, Global Policy & Government Affairs, Bristol Myers Squibb

10:15-10:30 Coffee Break


10:30-11:45 SmartCARE. A Fit-for-Future Cancer Survivorship Agenda

The centrepiece of Europe’s Beating Cancer Plan was the promise to fund a ‘Better Life for Cancer Patients Initiative’. It includes: a Cancer Survivor Smart-Card (SmartCARE project); a European Cancer Patient Digital Centre; and official EU studies on the return-to-work needs of cancer survivors and the forms of discrimination they may encounter, including from financial services providers. The Survivorship and Quality of Life Session will take stock of the latest developments.  

With Survivorship and Quality of Life Network Co-Chairs Csaba Dégi and Nevenka Krčevski Škvarč, including speakers:

  • Kateřina Konečná MEP, Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Gabriella Pravettoni, Professor of Cognitive Psychology, University of Milan and Director, Psycho-Oncology Division, European Institute of Oncology
  • Lesley Smith, Senior Programme Manager for Living With and Beyond Cancer (LWBC), NHS England
  • Anita Kienesberger, Member, Patient Advisory Committee, European Cancer Organisation, and Chair, Childhood Cancer International Europe Committee
  • Alexander Zehnder, Global Head of Oncology, Sanofi

11:45-12:00 Coffee Break


12:00-13:15 Embedding Outcome Measurement in Quality Cancer Care: Where Are We Now?

Across Europe, with an EU level cancer plan now complementing an array of national cancer plans, and a noteworthy focus on achieving an EU Network of Comprehensive Cancer Centres, how can we gain a fuller picture of the interventions and investments that yield the strongest improvements in outcomes? To such questions directors of pioneer cancer centres across Europe have been providing significant focus with the session providing an opportunity for sharing of experience and perspective. This will including exchange with patient advocates and the healthcare industry for their insights on fit-for-purpose outcome measurement in oncology.

With Quality Cancer Care Network Co-Chairs Simon Oberst and Fedro Peccatori, including speakers:

  • Deirdre Clune MEP, Member, Special Committee on the COVID-19 pandemic (COVI)
  • Jean-Yves Blay, President, French Federation of Cancer Centres, Unicancer
  • Yvonne Wengström, Professor, Karolinska Institute
  • Cinzia Brunelli, Researcher, Instituto Nazionale dei Tumori, Milan
  • Jan Van Der Meulen, Professor of Clinical Epidemiology, London School of Hygiene and Tropical Medicine
  • Anne-Marie Baird, President, Lung Cancer Europe
  • Jamie Partridge, Senior Director, Global Health Economics & Outcomes Research, Oncology, Bayer Pharmaceuticals

13:15-14:15 Lunch Break


14:15-15:30 The Oncology Workforce: We Must Act – and INTERACT – to Provide Effective and Equitable Cancer Care

Effective and equitable cancer care does not only concern the provision of advanced medications and machinery. It requires teams of trained professionals who bring multidisciplinary and multi-professional care to life. This is where INTERACT-EUROPE comes into play, our recently awarded 18-month EU4Health project. Together, we aim to set the standard for inter-specialty cancer training in Europe.

During this session, we will look at the level to which current EU policy is supporting the growth and development of oncology professions. We will also explore new technological advances and ways to bolster the resilience of the oncology workforce, especially considering the experiences of Covid-19.

With Workforce Network Co-Chairs Mirjam CrulWendy Oldenmenger and Beate Rau, including speakers:

  • Alessandra Moretti MEP, Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Kim Benstead, Co-Chair, INTERACT-EUROPE project
  • Niall O’Higgins, Co-Chair, INTERACT-EUROPE project
  • Matti Aapro, Chair, INTERACT-EUROPE Advisory Board, and Past President, European Cancer Organisation
  • Isabel Teresa Rubio, President-Elect, European Society of Surgical Oncology (ESSO)
  • Estelle Lecointe, Co-Chair, Sarcoma Patients Euro Net Association and Member, Patient Advisory Committee, European Cancer Organisation
  • Markus Kosch, Head of Oncology Europe, Daiichi Sankyo

15:30-15:45 Coffee Break


15:45-17:00 Session from the Special Network: Impact of the War in Ukraine on Cancer

> In collaboration with London Global Cancer Week

With Network Co-Chairs Andreas Charalambous, President, and Eric Winer, American Society of Clinical Oncology's President, including speakers:

  • Hans Kluge, Regional Director, World Health Organization Europe (WHO Europe)
  • Sandra Gallina, Director-General, DG SANTE
  • Richard Sullivan, Director, Institute of Cancer Policy; Editor-in-Chief, Journal of Cancer Policy; Emergency Committee Member, World Health Organization (WHO)
  • Roman Shyyan, Surgical Oncologist, Lviv State Regional Oncology Treatment and Diagnostic Center, Ukraine
  • Anna Uzlova, CEO, Inspiration Family Ukraine
  • Bettina Ryll, Founder, Melanoma Patient Network Europe
  • Andy Powrie-Smith, Executive Director of Communications & Partnerships, European Federation of Pharmaceutical Industries and Associations (EFPIA)

17:00-17:15 Coffee Break


17:15-18:15 The EU’s Cancer Policy Agenda: A Progress Report and Sense Check

Fewer issues are closer to the heart of every citizen than the health and wellbeing of themselves and those they love. The EU’s ambitious agenda on cancer has a clear and real prospect of changing and improving lives by helping to reduce cancer incidence, speeding early detection of cancer, enhancing treatment and outcomes, upscaling European cancer research, and embedding new foundational approaches to cancer survivorship and follow-up care. Implementation of Europe’s Beating Cancer Plan and the EU Research Mission on Cancer are advancing at pace. The annual European Cancer Summit serves as a time and a place for the European cancer community to convene together and share views on the progress made so far, bring attention to any roadblocks in delivery, and cast eyes to the next Missions, Plans and Actions to come. 

With Andreas Charalambous, President, and Gilly Spurrier-Bernard, European Cancer Summit 2022 Co-Chair, including speakers:

  • Stella Kyriakides, European Commissioner for Health and Food Safety
  • Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth
  • Jakub Dvořáček, Deputy Minister for the Czech Presidency of the Council of the European Union
  • Tomislav Sokol MEP, Secretary General, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Bente Mikkelsen, Director, Non-Communicable Diseases, World Health Organization (WHO)
  • Alexandru Eniu, Deputy Scientific Director, European School of Oncology (ESO)

 

Thursday 17 November 2022

9:00-10:15 Saving Lives by Anticipating Actions: Getting it right on Screening and Early Detection

This has been a landmark year for Europe’s Beating Cancer Plan, especially in early detection and its screening pillar. In March, the European Commission issued its latest scientific advice: a long-overdue update on EU recommendations to Member States on cancer screening. Notably, scientific advisors included new advice on lung, prostate and gastric cancer screening, alongside the already existing advice to countries on breast, cervical and colorectal cancer screening.

This summit session will hear from those most closely involved in the advisory process. They will  discuss the implementation journey ahead for the new recommendations, and how early detection needs can be met through coordinated policy interventions beyond screening.

With Prevention, Early Detection and Screening Network Co-Chairs Isabel Teresa Rubio and Jan van Meerbeeck, including speakers:

  • Nicolás González Casares MEP, Member, Committee on the Environment, Public Health and Food Safety (ENVI)
  • Gilberto Lopes, Editor-in-chief, JCO Global Oncology, American Society of Clinical Oncology
  • Dorothy Keefe, Chief Executive, Cancer Australia
  • Stefan Constantinescu, President, Federation of European Academies of Medicine (FEAM)
  • Rebecca Fitzgerald, Co-Chair, SAPEA Project, and Professor of Cancer Prevention at the University of Cambridge, UK, Interim Director of the MRC Cancer Unit
  • Rachel Giles, Chair, International Kidney Coalition
  • Gavin Lewis, Vice-President, Global Head of Market Access, AMGEN

10:15-10:30 Coffee Break


10:30-11:45 Better Than Before Is Possible: The Essential Rebuilding Blocks for Cancer Services After Covid-19

It is reasonable to consider the worst of the Covid-19 pandemic to be behind us, without diminishing vigilance for the winter ahead. Following the evidence, recommendations and political will generated by the Covid-19 and Cancer Time to Act campaign, what is the present status of the build back and what are the pressing priorities for action? Guided by information from the Time To Act Data Navigator, the session will hear from leading patients, healthcare professionals, politicians and industry speakers working at the front end of cancer service response and build back following the challenges created by the Covid-19 pandemic. The session will also describe latest recommendations from the cancer community to Governments and the EU on cancer service recovery and re-building, via an update to the Covid-19 and Cancer Network’s 7 point plan.

With Special Network on the Impact of Covid-19 on Cancer Co-Chairs Mirjam Crul and Mark Lawler, including speakers:

  • Dolors Montserrat MEP, Rapporteur, Special Committee on the Covid-19 Pandemic (COVI), and Former Spanish Health Minister
  • Natasha Azzopardi-Muscat, Director of the Division of Country Health Policies and Systems, WHO Europe
  • Aasim Yusuf, Chief Medical Officer, Gastroenterologist, Shaukat Khanum Memorial Cancer Hospital and Research Centre, India
  • Natacha Bolaños, Head, Membership and Alliances, Lymphoma Coalition, and Member, Patient Advisory Committee, European Cancer Organisation
  • Faisal Mehmud, Vice President, International Developed Markets Medical Head, Pfizer Oncology

11:45-12:00 Coffee Break


12:00-13:00 Reflections on the Present and Future of Cancer Care: Perspective of Young Cancer Professionals

> In collaboration with EU40

With Andreas Charalambous, President, and Ajay Aggarwal, Summit Co-Chair, including speakers:

  • Sara Cerdas MEP, Board Member, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Nicolae Stefanuta MEP, Board Member, EU40, and Member, Committee on the Environment, Public Health and Food Safety (ENVI)
  • Andre Ilbawi, Cancer Control Officer, World Health Organization (WHO)
  • Sebastian Arias, Global Access Policy Leader, Roche

And the best authors of chosen abstracts will also take part in this session.

13:00-13:45 Lunch Break (including meet the author)


13:45-15:00 Health Systems and Treatment Optimisation: Scanning the Political Horizons

The health system and treatment optimisation agenda, as promoted in consensus resolution and declarations of previous European Cancer Summits, continues to make elements of progress under the present EU political cycle. However, could more be reasonably expected beyond the immediate political horizon? This session of the European Cancer Summit will facilitate exchange and the sharing of achievable policy ambition to bring about sought after reorientation of health systems and research approaches in cancer. 

With Health Systems and Treatment Optimisation Network Co-Chairs Denis Lacombe and Yolande Lievens, including speakers:

  • Véronique Trillet-Lenoir MEP, Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Gauthier Bouche, Director of Clinical Research, Anticancer Fund
  • Michail Ignatiadis, Chair, Breast Cancer Group, European Organization for Research and Treatment of Cancer (EORTC)
  • Katie Spencer, Academic Clinical Oncologists, University of Leeds
  • Jan Geissler, CEO and Founder, Patvocates

15:00-15:15 Coffee Break


15:15-16:30 Protecting Europe: Eliminating the Cancers Caused by HPV

Now is the time for decisive action on HPV. The PROTECT-EUROPE project, funded by the EC and led by ECO with some 35 partners from 17 countries, will contribute to an increase in vaccine confidence among parents, carers and young people. It will increase vaccine uptake in all genders in line with the commitment in Europe's Beating Cancer Plan. PROTECT-EUROPE launches in January 2023.

WHO Europe's new Roadmap to accelerate the elimination of cervical cancer across the region aims to increase HPV vaccination rates (although primarily in girls), improve screening programmes (using HPV DNA testing and self-sampling), and improve access to treatment and care. The Roadmap provides the basis for further actions to tackle all the cancers caused by HPV.

Single-dose HPV vaccination, this year recommended by the WHO globally and already approved for the UK, should make it easier and cheaper for vaccine programmes to switch to gender-neutral. 

Taking advantage of these developments, ECO's 'Action Now on HPV' project will support advocacy work in countries which are falling behind in HPV cancer elimination. This year, pilots will start in Romania and Bulgaria and, in 2023, a total of up to 10 countries will be engaged. 

With HPV Action Network Co-Chairs Daniel Kelly and Rui Medeiros, including speakers:

  • Alin Mituta MEP, Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Patrick Howard, Penile Cancer Survivor
  • Clare Bennett, Reader, School of Healthcare Sciences, and Co-Director, Wales Centre for Evidence Based Care
  • Daisy Le, Assistant Research Professor of Health Disparities and Oncology, George Washington University School of Nursing
  • Andrea Gerosa, Founder, ThinkYoung

 
16:30-16:45 Coffee Break


16:45-18:00 Bringing Digital Transformation of Cancer Care to Fruition  

As set out in the ECO consensus paper, No Stopping Us Now!, the benefits of digital technology for improving cancer care are clear. Yet frustration persists with a perception of slower than hoped for progress in major areas such as international oncology data collaboration, and sufficient preparation of health systems, including oncology professionals, for larger scale adoption and uptake in areas such as Artificial Intelligence. This session will take perspectives from national ministries, international oncology leaders and EU decision-makers about the current state of the art and the realities of digital change management in the oncology, with reference to present political priorities such as the establishment of a European Health Data Space. 

With Digital Health Network Network Co-Chairs Carlo Catalano and Wim Oyen, including speakers:

  • Laurence Court, Director, The Radiation Planning Assistant Project, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Centre
  • Denis Costello, Executive Director, CML Advocates Network
  • Ebba Hallersjö Hult, Co-founder and Head of Vision Zero Cancer

18:00-18:30 Delivering Effective & Equitable Care Together: The Next Steps

After two full days of sessions exploring how Europe can move further forward faster in making cancer care more effective and equitable, the final session of the European Cancer Summit will give emphasis to the next steps in bringing ideas to reality and converting words into action.

The European Cancer Organisation will launch a new mechanism by which cancer policy connection between Brussels and national capitals can be encouraged and strengthened, including through systematic best practice exchange and the nurturing of fresh cross-border cooperation on cancer.

With Andreas Charalambous, President, Ajay Aggarwal, Gilly Spurrier-Bernard, our European Cancer Summit 2022 Co-Chairs , and leading cancer policy makers from across Europe.

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge Regional Director, World Health Organization Europe (WHO Europe)
  • Jakub Dvořáček Deputy Health Minister for the Czech Presidency of the Council of the European Union
  • Sara Cerdas MEP Board Member, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Deirdre Clune MEP Member, Special Committee on the Covid-19 Pandemic (COVI)

The European Cancer Organisation is committed to delivering equitable and effective cancer care globally, translating the best evidence to policy and practice.

We thank those that submitted their research abstract and look forward to notifying you in early October of the selected abstracts for this year's European Cancer Summit. 

Up until 15 September, we were accepting research abstracts connected to our key Focused Topic Networks and priority areas within Europe’s Beating Cancer Plan and the EU Cancer Mission recommendations.

This included research into:

We have a limit on the number of abstracts that we can accept for poster and oral presentation during the Summit. The presentations will form part of a special session with young cancer professionals and leaders at the Summit on Day 2. Abstracts will be chosen to ensure representation across all the Focused Topic Networks and the lead author will receive free registration to the Summit, although it is not mandatory to attend. The accepted abstracts will also be published in the Journal of Cancer Policy.

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge Regional Director, World Health Organization Europe (WHO Europe)
  • Jakub Dvořáček Deputy Health Minister for the Czech Presidency of the Council of the European Union
  • Sara Cerdas MEP Board Member, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Deirdre Clune MEP Member, Special Committee on the Covid-19 Pandemic (COVI)

Supporters of the European Cancer Summit 2022

  • Member Societies of the European Cancer Organisation
  • Patient Advocacy Groups of the European Cancer Organisation
  • Community 365 of the European Cancer Organisation
  • Journal of Cancer Policy
  • touchONCOLOGY
  • Cancer World
  • ecancer
  • visit.brussels
  • Wondr Medical
  • EU40
  • London Global Cancer Week

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge Regional Director, World Health Organization Europe (WHO Europe)
  • Jakub Dvořáček Deputy Health Minister for the Czech Presidency of the Council of the European Union
  • Sara Cerdas MEP Board Member, EU40, and Member, Special Committee on the Covid-19 Pandemic (COVI)
  • Deirdre Clune MEP Member, Special Committee on the Covid-19 Pandemic (COVI)